<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13719-bib-0016">
 <label>16</label>
 <mixed-citation publication-type="journal" id="cas13719-cit-0016">
  <string-name>
   <surname>Ogura</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Itoh</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Ishizawa</surname>
   <given-names>K</given-names>
  </string-name>, et al. 
  <article-title>Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced‐stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)</article-title>. 
  <source xml:lang="en">Leuk Lymphoma</source>. 
  <year>2013</year>;
  <volume>54</volume>:
  <fpage>46</fpage>‐
  <lpage>52</lpage>.
  <pub-id pub-id-type="pmid">22712838</pub-id>
 </mixed-citation>
</ref>
